In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
GANYMED ANNOUNCES LICENSE OF WT1 IMMUNOTHERAPY RIGHTS BY CORIXA AND KIRIN
Selexis Signs Commercial License Agreement with GANYMED Pharmaceuticals
Genmab and Semaia collaborate on cancer antibody therapeutics
Genmab and Immunex in new collaboration
ROCHE SELECTS TWO GENMAB ANTIBODIES AS CLINICAL CANDIDATES
Roche and Genmab reach second milestone
Genmab A/S (GNMSF.PK) acquires rights for 16 cancer targets from EUROPROTEOME AG
Millennium in-licenses novel target for colorectal cancer
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
